Development and Validation of High-Performance Thin Layer Chromatographic Method for the Simultaneous Estimation of Dapagliflozin and Vildagliptin in Fixed-Dose Combination. [PDF]
Krishnamoorthy YV +2 more
europepmc +1 more source
Comparison of renal function of the patients receiving linagliptin or vildagliptin in uncontrolled type 2 diabetes mellitus: An observational study in the backdrop of the COVID-19 pandemic. [PDF]
Chaudhuri S +3 more
europepmc +1 more source
Sitagliptin to Patients With Postprandial Hypotension Without Diabetes. [PDF]
Ishikawa J, Toba A, Harada K.
europepmc +1 more source
Vildagliptin modulates the microbiota and induces an immunometabolic profile compatible with neuroprotection in type 2 diabetes. [PDF]
de Macedo JCC +9 more
europepmc +1 more source
Therapeutic impact of vildagliptin vs. gliclazide on insulin resistance and advanced glycated end product levels in newly diagnosed Egyptian diabetics: a randomized controlled trial. [PDF]
Elemary T +3 more
europepmc +1 more source
Antidiabetes agents and risk of incident depression in 686,522 people with type 2 diabetes mellitus: A 20-year population-based cohort study. [PDF]
Ho MTH +9 more
europepmc +1 more source
Vildagliptin and its Association with Bullous Pemphigoid. [PDF]
Meah A, Reddy KS, Rajeshwari KA.
europepmc +1 more source
The effects of vildagliptin on glycemic variability in patients with type 2 diabetes on premixed insulin therapy. [PDF]
Kong D +7 more
europepmc +1 more source
<i>Candida glabrata</i> Prostatitis: A Rare Case in a Patient With Type 2 Diabetes Mellitus on Dapagliflozin Treatment. [PDF]
Torres García EG +4 more
europepmc +1 more source
Unravelling the mechanism by which vildagliptin and linagliptin inhibit pyroptosis in lung injury through the NLRP3 inflammatory pathway in type 1 diabetic rats. [PDF]
Sedik AA +3 more
europepmc +1 more source

